WNT10B在肺鳞癌组织中表达升高

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (10): 1389-1393.

WNT10B在肺鳞癌组织中表达升高

路琳^1,2, 顾艺荀¹, 徐兴祥³, 闵凌峰³, 陈彦亮¹, 王霄霖⁴, 陈勇^1*

1.苏北人民医院肿瘤科;
2.大连医科大学, 辽宁大连 116044;
3.苏北人民医院呼吸与重症内科;
4.苏北人民医院胸外科, 江苏扬州 225001

收稿日期:2019-09-16 修回日期:2020-01-02 出版日期:2020-10-05 发布日期:2020-09-29
通讯作者: ^* chenyong_jsyz@sina.com
基金资助:
国家自然科学基金(81302015);江苏省自然科学基金(BK20191218);扬州市“十三五”科教强卫专项经费(ZDRC201846);扬州市自然科学基金(YZ2014044,YZ2016108);江苏省“科教强卫工程”青年医学人才专项基金(QNRC2016319)

Expression of WNT10B is increased in lung squamous cell carcinoma

LU Lin^1,2, GU Yi-xun¹, XU Xing-xiang³, MIN Ling-feng³, CHEN Yan-liang¹, WANG Xiao-lin⁴, CHEN Yong^1*

1. Department of Medical Oncology;
2. Dalian Medical University, Dalian 116044, China;
3. Department of Respiratory and Intensive Medical;
4. Department of Thoracic Surgery, Subei People's Hospital, Yangzhou 225001

Received:2019-09-16 Revised:2020-01-02 Online:2020-10-05 Published:2020-09-29
Contact: ^* chenyong_jsyz@sina.com

摘要/Abstract

摘要： 目的探讨WNT10B在肺鳞癌组织中的表达情况并探讨其与临床病理特征及预后之间的关系。方法选择上海芯超生物科技有限公司提供的75例附有随访信息的肺鳞癌组织芯片,免疫组化法检测WNT10B蛋白的表达;卡方检验分析WNT10B表达与肺鳞癌临床病理因素之间的联系;Kaplan-Meier 生存分析和log-rank 检验以及Cox 比例风险模型分析WNT10B表达与肺鳞癌患者的预后。结果 WNT10B在肺鳞癌组织中的表达均显著高于癌旁组织(P＜0.001);WNT10B高表达与肿瘤T分期、肿瘤分化程度显著相关(P＜0.05);WNT10B表达与肺鳞癌患者的预后具有相关性(P＜0.05),WNT10B是肺鳞癌预后的独立相关因素(P＜0.05)。结论 WNT10B参与肺鳞癌的发生发展过程,有望成为肺鳞癌的一个新的肿瘤标志物及预后指标。

关键词: 肺鳞癌, 组织芯片, WNT10B, 预后, 免疫组化

Abstract: Objective To detect the expression of WNT10B in lung squamous cell carcinoma and to explore the correlation with pathologic feature and prognosis. Methods We collected 75 cases tissue chips of lung squamous cell carcinoma with follow-up information from Shanghai Outdo Biotech Co., ltd. The expression of WNT10B protein was examined by immunohistochemistry. Chi-squared test was used to analyze the correlation between WNT10B expression and pathological factors. Survival analysis, log-rank test and Cox proportional hazard model were employed to analyze the relationship between WNT10B expression and prognosis of patients. Results The expression of WNT10B in cancerous tissue was significantly higher than matched adjacent non-cancerous tissue (P＜0.001). High expression of WNT10B was significantly correlated with T stage and tumor differentiation (P＜0.05). WNT10B expression was correlated with the prognosis of patients (P＜0.05) and WNT10B was an independent correlation factor for the prognosis (P＜0.05). Conclusions WNT10B is involved in the occurrence and development of lung squamous cell carcinoma and is expected to be a new tumor marker and prognosis indicator.

Key words: lung squamous cell carcinoma, tissue chips, WNT10B, prognosis, immunohistochemistry

中图分类号:

R734

路琳, 顾艺荀, 徐兴祥, 闵凌峰, 陈彦亮, 王霄霖, 陈勇. WNT10B在肺鳞癌组织中表达升高[J]. 基础医学与临床, 2020, 40(10): 1389-1393.

LU Lin, GU Yi-xun, XU Xing-xiang, MIN Ling-feng, CHEN Yan-liang, WANG Xiao-lin, CHEN Yong. Expression of WNT10B is increased in lung squamous cell carcinoma[J]. Basic & Clinical Medicine, 2020, 40(10): 1389-1393.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries[J].Ca Cancer J Clin, 2018, 68: 394-424.
[2] Mitsudomi T, Kosaka T, Yatabe Y. Biological and clinical implications of EGFR mutations in lung cancer[J].Int J Clin Oncol, 2006, 11: 190-198.
[3] Tanaka T, Matsuoka M, Sutani A, et al. Frequency of and variables associated with the EGFR mutation and its subtypes[J]. Int J Cancer, 2010, 126: 651-655.
[4] Perez-Moreno P, Brambilla E, Thomas R, et al. Squa-mous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities[J]. Clin Cancer Res, 2012, 18: 2443-2451.
[5] Zeng X, Zhang Y, Xu H, et al. Secreted frizzled related protein 2 modulates epithelial-mesenchymal transition and stemness via Wnt/β-Catenin signaling in choriocarcinoma[J]. Cell Physiol Biochem, 2018, 50: 1815-1831.
[6] Abitbol S, Dahmani R, Coulouarn C, et al. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation[J]. J Hepatol, 2018, 68: 1203-1213.
[7] Wu XD, Bie QL, Zhang B, et al. Wnt10B is critical for the progression of gastric cancer[J]. Oncol Lett, 2017, 13: 4231-4237.
[8] Peng L, LIU Z, XIAO J, et al.microRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway[J]. Oncol Rep, 2017, 38: 301-308.
[9] Chen Y, Zeng C, Zhan Y, et al. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b[J]. Oncogene, 2017, 36: 4692-4705.
[10] 卢宇青. Wnt10a/Wnt10b及其Wnt/β-catenin通路在子宫内膜癌患者中的作用机制研究[J]. 中国医学创新, 2017, 19: 22-25.
[11] 陈刚,丁华,刁统伟,等.结直肠癌预后分子标志物WNT10B及WNT家族对结直肠癌的影响[J]. 中国现代普通外科进展, 2018, 7: 543-548.
[12] Chen H, Wang Y, Xue F. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/beta-catenin pathway[J]. Oncol Rep, 2013, 29: 507-514.

[1]	武坤, 聂波, 李云涛, 杨金荣, 程沈菊, 李艳红, 史明霞. 外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用[J]. 基础医学与临床, 2022, 42(6): 871-875.
[2]	哈提米汗·买买提, 姑丽克孜·买买提热夏提, 李俞霆, 周常慧, 李榕. CBX7蛋白在宫颈癌中的表达及其临床意义[J]. 基础医学与临床, 2022, 42(5): 721-725.
[3]	苏路瑛, 黄容, 邹定峰, 许富, 李凯, 卢艳, 缪时英, 王琳芳, 宋伟. 多组学分析发现LAMC2是调节泛癌微环境的关键因子[J]. 基础医学与临床, 2022, 42(4): 545-552.
[4]	黄容, 张键, 车旭. SLC4A10表达水平对肝癌患者预后的影响[J]. 基础医学与临床, 2022, 42(3): 461-466.
[5]	李阳芳胡慧敏. PTTG和p21作为无功能垂体瘤放射治疗预后的分子标志物[J]. 基础医学与临床, 2021, 41(9): 1253-1259.
[6]	崔仪, 韩振国. 224例中高危险度胃肠间质瘤手术根治程度结合靶向治疗的生存预后分析[J]. 基础医学与临床, 2021, 41(5): 667-673.
[7]	司斌, 张舒媛, 杨云云, 陈宇, 张伟丽. p21活化激酶2基因变异体rs3662C＞A与卒中风险和预后的关系及其对转录活性的影响[J]. 基础医学与临床, 2021, 41(4): 472-478.
[8]	陈志刚, 洪鹏, 杨斌, 田晓军, 王国良, 张树栋, 马潞林. 肾透明细胞癌行保留肾单位手术后复发风险预测模型的构建[J]. 基础医学与临床, 2021, 41(3): 409-414.
[9]	张悦怡李美姿杨莹韵杨爱明. 含TPR干扰素诱导蛋白在消化系统肿瘤中作用的研究进展[J]. 基础医学与临床, 2021, 41(11): 1662-1665.
[10]	王慧萍崔云英马晓森文进任卫东童安莉. 特发性醛固酮增多症的病理分型和手术预后[J]. 基础医学与临床, 2021, 41(10): 1481-1485.
[11]	张宁马辉辉王凡梁伟汪义纯吴炳山李庆新. 脑胶质瘤患者MGMT启动子甲基化和IDH1突变与临床预后相关[J]. 基础医学与临床, 2021, 41(10): 1476-1480.
[12]	何权, 刘丹瑜, 叶君, 张艳丽, 朱华栋, 蒋澄宇, 徐军. 5-羟色胺对重症社区获得性肺炎严重程度的预测研究[J]. 基础医学与临床, 2020, 40(9): 1195-1200.
[13]	胡晶晶, 童瑾. 通过与SARS和MERS的比较探索COVID-19远期并发症及防治措施[J]. 基础医学与临床, 2020, 40(7): 887-892.
[14]	陈佳阳杨宇飞易丹辉冯利. 中医治疗晚期食道癌分析及预后判别[J]. 基础医学与临床, 2020, 40(2): 182-186.
[15]	陈国雁, 冯晓波. 抑制miR-621表达促进人胃癌细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2020, 40(11): 1500-1505.